Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,812
Total Claims
$712K
Drug Cost
593
Beneficiaries
$1,201
Cost/Patient
Risk Score Breakdown 20/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+43%
Opioid rate vs peers
3.2% vs 2.2% avg
-15%
Cost per patient vs peers
$1,201 vs $1,411 avg
+15%
Brand preference vs peers
12.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.2%
Opioid Rate
282
Opioid Claims
$12K
Opioid Cost
15.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,066 claims · $509K
Generic: 7,666 claims · $199K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 88 | $86K |
| Tirzepatide | 53 | $61K |
| Semaglutide | 45 | $44K |
| Rivaroxaban | 29 | $36K |
| Dulaglutide | 37 | $35K |
| Dapagliflozin Propanediol | 36 | $34K |
| Empagliflozin | 13 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $17K |
| Budesonide/Formoterol Fumarate | 20 | $15K |
| Linagliptin | 13 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 19 | $12K |
| Estradiol | 87 | $11K |
| Levothyroxine Sodium | 476 | $10K |
| Atorvastatin Calcium | 576 | $9,880 |
| Gabapentin | 289 | $9,741 |
Prescribing Profile
Patient Profile
76
Avg Age
76%
Female
1.18
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About